Authors:
Naughton, BJ
Mylotte, JM
Ramadan, F
Karuza, J
Priore, RL
Citation: Bj. Naughton et al., Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia, J AM GER SO, 49(8), 2001, pp. 1020-1024
Authors:
Fischer, JS
Priore, RL
Jacobs, LD
Cookfair, DL
Rudick, RA
Herndon, RM
Richert, JR
Salazar, AM
Goodkin, DE
Granger, CV
Simon, JH
Grafman, JH
Lezak, MD
Hovey, KMO
Perkins, KK
Barilla-Clark, D
Schacter, M
Shucard, DW
Davidson, AL
Wende, KE
Bourdette, DN
Kooijmans-Coutinho, MF
Citation: Js. Fischer et al., Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis, ANN NEUROL, 48(6), 2000, pp. 885-892
Authors:
Russo, TA
Davidson, BA
Priore, RL
Carlino, UB
Helinski, JD
Knight, PR
Citation: Ta. Russo et al., Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in an Escherichia coli model of Gram-negative pneumonitis in rats, INFEC IMMUN, 68(5), 2000, pp. 2854-2862
Authors:
Rudick, RA
Cookfair, DL
Simonian, NA
Ransohoff, RM
Richert, JR
Jacobs, LD
Herndon, RM
Salazar, AM
Fischer, JS
Granger, CV
Goodkin, DE
Simon, JH
Bartoszak, DM
Bourdette, DN
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munchsauer, FE
O'Reilly, K
Priore, RL
Pullicino, PM
Scherokman, BJ
Wende, K
Weinstock-Guttman, B
Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
Authors:
McCann, SE
Trevisan, M
Priore, RL
Muti, P
Markovic, N
Russell, M
Chan, AWK
Freudenheim, JL
Citation: Se. Mccann et al., Comparability of nutrient estimation by three food frequency questionnaires for use in epidemiological studies, NUTR CANCER, 35(1), 1999, pp. 4-9
Authors:
Goodkin, DE
Priore, RL
Wende, KE
Campion, M
Bourdette, DN
Herndon, RM
Fischer, JS
Jacobs, LD
Cookfair, DL
Rudick, RA
Richert, JR
Salazar, AM
Granger, CV
Simon, JH
Alam, JJ
Bartoszak, DM
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munschauer, FE
Pullicino, PM
Scherokman, BJ
Weinstock-Guttman, B
Whitham, RH
Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486